Organization Profile

You just read:

In Toronto, Two International Leaders Share One Goal: Slow or Halt the Progression of Alzheimer's Disease with the Launch of Phase 3 Clinical Trials

News provided by

TauRx Therapeutics Ltd.

Jun 10, 2013, 16:20 ET